¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"cystic fibrosis transmembrane conductance regulator"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® cystic fibrosis ÇÑ±Û ³¶¼º¼¶À¯Áõ
¼³¸í   
  À¯Àüº´ÀÇ Çϳª·Î ¶¡»ù, ±â°üÁö¿¡¼­ Á¡¾×À» ºÐºñÇϴ »ù, ÀÌÀÚµîÀÇ ¿ÜºÐºñ»ù(¸ö ¹ÛÀ¸·Î ¾×ü¸¦ ºÐºñÇϴ »ù. ³»ºÐºñ»ùÀ» Á¦¿ÜÇÑ ¸ðµç »ùÀ» À̸¥´Ù)ÀÇ ÀÌ»óÀ» Æ¯Â¡À¸·Î Çϴ º´ÀÌ´Ù. Áß¿äÇÑ º´ÀûÀΠº¯È­´Â ÁַΠ±â°üÁö¿¡¼­ Á¡¾×À» ºÐºñÇϴ ºÐºñ»ù¿¡¼­ Áö³ªÄ¡°Ô Á¡µµ°¡ ³ôÀº Á¡¾×ÀÌ ºÐºñµÇ¾î ±â°üÁö¸¦ ¸·¾Æ È£ÈíÀå¾Ö¸¦ ÀÏÀ¸Å°´Â ÆóÀÇ º´ÅÍÀ̸ç, ¶¡¿¡¼­ °úµµÇÑ ÀüÇØÁú Æ¯È÷ ¿°È­³ªÆ®·ý(NaCl)ÀÌ ºÐºñµÇ¾î ¸ö¿¡ ÀüÇØÁúÀÌ ºÎÁ·ÇϰԠµÈ´Ù. ¶Ç ÀÌÀÚÀÇ ¼ÒÈ­¾×À» ºÐºñÇϴ ºÐºñ»ùÀÇ ÀÌ»óÀ¸·Î ÀÌÀÚ°üÀÌ ¸·È÷°Å³ª ÀÌÀÚÀÇ ±â´ÉÀÌ ¶³¾îÁ®¼­ ¼ÒÈ­ÀÇ Àå¾Ö¸¦ ÀÏÀ¸Å°±âµµ ÇÑ´Ù. À¯Å°迡 ¸¹À¸¸ç ¿ì¸®³ª¶ó¿¡´Â ¾ÆÁÖ µå¹°´Ù.
¿µ¹® fibrosis ÇÑ±Û ¼¶À¯Áõ, ¼¶À¯È­
¼³¸í   
  ¾Æ±³Áú¼¶À¯¸¦ Çü¼ºÇϴ ¼¶À¯Á¶Á÷ÀÇ Áõ½ÄÀ¸·Î ¸öÀÇ ½ÇÁú¼¼Æ÷ÀÇ ±«»ç³ª ¼Õ»ó¿¡ À̾ ³ªÅ¸³ª´Â °æ¿ì°¡ º¸ÅëÀÌ´Ù. µÎ ´Ü°è, Áï ¼Õ»óºÎÀ§¿¡¼­ ¼¶À¯¸ð¼¼Æ÷ÀÇ ÀÌÁÖ¿Í Áõ½Ä, ±×¸®°í ¼¶À¯¸ð¼¼Æ÷¿¡ ÀÇÇÑ ¼¼Æ÷ÀÇ ¹ÙÅÁÁú ÃàÀûÀ¸·Î ÁøÇàµÈ´Ù. ÇǺÎÀÇ °æ¿ì ÁøÇdz» ¼¶À¯¸ð¼¼Æ÷ÀÇ Áõ½Ä°ú ¾Æ±³Áú ¼¶À¯ÀÇ Áõ½ÄÀÌ Àִ °æ¿ì¸¦ ¼¶À¯È­, °ÅÀÇ ¾Æ±³Áú ¼¶À¯·Î¸¸ ±¸¼ºµÇ´Â °æ¿ì¸¦ °æÈ­¶ó°í ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cystic fibrosis
    ³¶¼º¼¶À¯Áõ
  • airway conductance
    ±âµµÀüµµµµ
  • conductance
    Àüµµµµ
  • hydraulic conductance
    ¼ö·ÂÇÐÀûÀüµµµµ
  • membrane conductance
    ¸·Àüµµµµ
  • growth regulator
    ¼ºÀåÁ¶ÀýÀÎÀÚ
  • heating regulator
    °¡¿­Á¶Àý±â
  • macromolecular regulator
    °íºÐÀÚÁ¶ÀýÀÎÀÚ
  • regulator
    1. Á¶ÀýÀÎÀÚ 2. Á¶Àý±â
  • regulator gene
    Á¶ÀýÀ¯ÀüÀÚ
  • circumscribed fibrosis
    ±¹ÇѼ¶À¯Áõ
  • cortical stromal fibrosis
    °ÑÁú¹ÙÅÁÁú¼¶À¯Áõ, ÇÇÁú±âÁú¼¶À¯Áõ
  • endomyocardial fibrosis
    ½É³»¸·½É±Ù¼¶À¯Áõ
  • fibrosis
    1. ¼¶À¯Áõ 2. ¼¶À¯È­
  • idiopathic pulmonary fibrosis
    Ư¹ßÆó¼¶À¯Áõ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • regulator gene
    Á¶ÀýÀ¯ÀüÀÚ
  • transmembrane potential
    ¸·ÀüÀ§, ¸·Àü¾Ð
  • regulator
    Á¶ÀýÀÎÀÚ, Á¶Àý±â
  • transmembrane transport
    ¸·¿î¹Ý
  • fibrosis
    ¼¶À¯Áõ, ¼¶À¯È­
  • annulus fibrosis
    ¼¶À¯Å×
  • idiopathic pulmonary fibrosis
    Ư¹ß¼ºÆó¼¶À¯Áõ
  • interstitial fibrosis
    »çÀÌÁú¼¶À¯Áõ, »çÀÌÁú¼¶À¯È­
  • cystic
    ³¶-, ³¶Á¾-
  • cystic duct
    ¾µ°³ÁָӴϰü
  • atypical cystic hyperplasia
    ºñÁ¤Çü³¶¼º½ÄÁõ
  • cystic hygroma
    ³¶¸²ÇÁ°üÁ¾, ÁָӴϸ²ÇÁ°üÁ¾
  • cystic lesion
    ³¶º´ÅÍ
  • cystic neoplasm
    ³¶Á¾
  • cystic medial necrosis
    ³¶¼ºÁßÃþ±«»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • transmembrane channel
    ¸·Åë·Î
  • transmembrane potential difference
    ¸·ÀüÀ§Â÷ÀÌ
  • transmembrane potential
    ¸·ÀüÀ§, ¸·Àü¾Ð
  • transmembrane transport
    ¸·¿î¹Ý
  • airway conductance
    ±âµµÀüµµ
  • conductance
    Àüµµµµ
  • chord conductance equation
    Æò±ÕÀüµµ¹æÁ¤½Ä
  • hydraulic conductance
    ¼ö·ÂÇÐÀûÀüµµµµ
  • membrane conductance
    ¸·Àüµµµµ
  • growth regulator
    ¼ºÀåÁ¶ÀýÀÎÀÚ
  • regulator gene
    Á¶ÀýÀ¯ÀüÀÚ
  • heating regulator
    °¡¿­Á¶Á¤±â
  • macromolecular regulator
    °íºÐÀÚÁ¶ÀýÀÎÀÚ
  • regulator
    Á¶ÀýÀÎÀÚ, Á¶Àý±â
  • arteriocapillary fibrosis
    µ¿¸Æ¸ð¼¼Ç÷°ü¼¶À¯Áõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Cystic fibrosis
    ³¶¼º¼¶À¯Áõ(Òªàøàéë«ñø)
  • airway conductance
    ±âµµÀüµµµµ(ѨԳîîÓôöô)<ÄÜ´öÅϽº>. ¸¶Ãë±âµµÀüµµ¼º.
  • growth regulator
    ¼ºÀåÁ¶ÀýÀÎÀÚ.
  • heating regulator
    °¡¿­Á¶Á¤±â(Ê¥æððàïÒÐï).
  • regulator gene
    Á¶ÀýÀ¯ÀüÀÚ(ðàï½ë¶îîí­).
  • regulator of surface tension
    Ç¥¸éÀå·ÂÁ¶Á¤Á¦(øúØüíåæ³ðàïÚð¥).
  • Cystic duct
    ´ã³¶°ü(ÓÅҥη)
  • acne, cystic
    ³¶Æ÷¼º ¿©µå¸§, ÁÂâ
  • acquired cystic disease of the kidney
    ÈÄõ¼º ½Å³¶Æ÷Áúȯ
  • adenoid cystic carcinoma
    ¼±¾ç³¶¼º¾ÏÁ¾(àÍåÆÒ¥àõäßðþ)
  • aorta,cystic medionecrosis
    ³¶Çü Á߸·±«»ç(Ò¥úþñ騝ÎÕÞÝ)
  • hygroma, cystic
    È÷±×·Î¸¶
  • Fibrosis
    ¼¶À¯Áõ(àéë«ñø), ¼¶À¯È­(àéë«ûù)
  • Hamman Rich syndrome =diffuse interstitial pulmonary fibrosis
    ÇØ¸Õ- ¸®Ä¡ÁõÈıº.
  • arteriocapillary fibrosis
    µ¿¸Æ¸ð¼¼Ç÷°ü¼¶À¯Áõ(¡­Ù¾á¬úìηàéë«ñø).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cystic fibrosis
    ³¶¼º¼¶À¯Áõ(¡­àéë«ñø).
  • cystic fibrosis
    ³¶¼º¼¶À¯Áõ
  • cystic fibrosis
    ³¶¼º¼¶À¯Áõ(¡­àéë«ñø)
  • cystic fibrosis of pancreas
    ÃéÀå³¶¼º¼¶À¯Áõ(õýíôÒ¥àõàéë«ñø).
  • pancreatic cystic fibrosis
    ÃéÀå³¶¼º ¼¶À¯Áõ(õýíôÒ¥àõ àéë«ñø)
  • restriction fragment length polymorphism,in cystic fibrosis
    ³¶¼º¼¶À¯Áõ(ÀÇ)¡­(Ò¥àõàéë«ñø¡­)
  • airway conductance
    ±âµµÀüµµµµ(ѨԳîîÓôöô)<ÄÜ´öÅϽº>. ¸¶Ãë±âµµÀüµµ¼º.
  • chord conductance equation
    Æò±Õ Àüµµ ¹æÁ¤½Ä(øÁгîîÓôÛ°ïïãÒ)
  • conductance
    Àüµµµµ(îîÓôöô), ÄÜ´öÅϽº.
  • hydraulic conductance
    ¼ö·ÂÇÐÀû Àüµµµµ(â©ÕôùÊîÜ îîÓôÓø).
  • membrane conductance
    ¸·Àüµµµµ(دîîÓôÓø)
  • transmembrane channel
  • transmembrane potential
    ¸·ÀüÀ§, ¸·Àü¾Ð
  • transmembrane potential
    ¸·ÀüÀ§.
  • transmembrane potential difference
    ¸·ÀüÀ§Â÷ÀÌ.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Fibrosis
    ¼¶À¯È­
    [¿¾ ¿ë¾î] ¼¶À¯È­
  • Cystic artery
    ¾µ°³°¡Áö
    [¿¾ ¿ë¾î] ´ã³¶µ¿¸Æ
  • Cystic duct
    ¾µ°³°ü
    [¿¾ ¿ë¾î] ´ã³¶°ü
  • Cystic node
    ¾µ°³¸²ÇÁÀý
    [¿¾ ¿ë¾î] ´ã³¶ÀÓÆÄÀý
  • Cystic vein
    ¾µ°³Á¤¸Æ
    [¿¾ ¿ë¾î] ´ã³¶Á¤¸Æ
  • Cystic duct
    ¾µ°³ÁָӴϰü
    [¿¾ ¿ë¾î] ´ã³¶°ü
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Symmer's pipestem fibrosis
    ½Ã¸ÓÆÄÀÌÇÁ¼¶À¯È­
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • conductance
    Àüµµµµ(îîÓôÓø)
  • transmembrane potential
    ¸·È¾´ÜÀüÀ§(دüôÓ¨ï³êÈ)
  • transmembrane protein
    ¸·È¾´Ü ´Ü¹éÁú(دüôÓ¨Ó±ÛÜòõ)
  • regulator-constitutive mutant
    Á¶ÀýÀÚ ±¸¼º º¯ÀÌü(ðàï½íºÏ°à÷ܨì¶ô÷)
  • regulator element
    Á¶Àý¼Ò(ðàï½áÈ)
  • regulator gene
    Á¶Àý À¯ÀüÀÚ(ðàï½ë¶îîí­)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cystic fibrosis
    ³¶¼º¼¶À¯Á¾
  • pancreatic cystic fibrosis
    ÃéÀå³¶¼º¼¶À¯Áõ
  • regulator
    Á¶Àý±â, Á¶Á¤±â
  • adenoid cystic carcinoma
    ¼±¾ç³¶¼º¾ÏÁ¾
  • cystic
    ³¶¼ºÀÇ
  • cystic degeneration
    ³¶º¯¼º
  • cystic duct
    ´ã³¶°ü
  • cystic kidney
    ³¶½Å
  • cystic lymphangioma
    ³¶¼º¸²ÇÁ°üÁ¾
  • fibrosis
    ¼¶À¯Áõ, ¼¶À¯È­
  • idiopathic retroperitoneal fibrosis
    Ư¹ß¼ºÈĺ¹¸·°­¼¶À¯Áõ
  • myocardial fibrosis
    ½É±Ù¼¶À¯Áõ
  • pulmonary fibrosis
    Æó¼¶À¯Áõ
  • radiation fibrosis
    ¹æ»ç¼±¼¶À¯Áõ
  • radiation fibrosis of lung
    ¹æ»ç¼±Æó¼¶À¯Áõ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CFTR cystic fibrosis transmembrane conductance regulator
CFF critical flicker fusion [test]; critical fusion frequency; cystic fibrosis factor; Cystic Fibrosis F...
CFP chronic false positive; Clinical Fellowship Program; cyclophosphamide, fluorouracil, prednisone; cys...
TMP thiamine monophosphate; thymidine monophosphate; thymidine-5'-monophosphate; thymolphthalein monopho...
MF   1) Myelo-Fibrosis
    = Agnogenic Myeloid Metaplasia with Myelo-F...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CFTR Cystic Fibrosis Transmembrane Conductance Regulator
CFTR Cystic Fibrosis Transmembrane Conductance Regulator Gene
CFTR cystic fibrosis transmembrane conductance regulator protein
CFTR Cystic Fibrosis Transmembrane Regulator
CFTR CF transmembrane conductance regulator
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cystic fibrosis
    ³¶¼º ¼¶À¯Áõ, ³¶Æ÷¼º ¼¶À¯Áõ, ³¶Æ÷¼º ¼¶À¯È­Áõ
  • transmembrane potential difference
    ¸·ÀüÀ§ Â÷ÀÌ
  • airway conductance
    ±âµµ Àüµµµµ, ±âµµ Àüµµ¼º
  • chord conductance equation
    Æò±Õ Àüµµ ¹æÁ¤½Ä
  • hydraulic conductance
    ¼ö·ÂÇÐÀû Àüµµµµ
    ¹°¸® ¹ýÄ¢¿¡ µû¸¥ ¾×üÀÇ ÀÛ¿ëÀ» Ãë±ÞÇÏ´Â ¹°¸®ÇÐÀÇ ÇÑ ¿µ¿ª.
  • amperage regulator
    °üÀü·ù Á¶Àý±â
  • macromolecular regulator
    °íºÐÀÚ Á¶Àý ÀÎÀÚ
  • regulator gene
    Á¶Àý À¯ÀüÀÚ
  • voltage regulator
    °üÀü¾Ð Á¶Àý±â
  • congenital fibrosis syndrome
    ¼±Ãµ ¼¶À¯Áõ ÁõÈıº
  • endomyocardial fibrosis
    ½É³»¸· ¼¶À¯Áõ
    ±×¸® ¸¹Áö ¾ÊÀº ÁúȯÀ¸·Î ÁÖ·Î Á½ɽÇÀÇ ½É³»¸·¿¡ ±¹¼ÒÀû ¶Ç´Â ¹Ì¸¸¼ºÀÇ ¼¶À¯ ź·Â¼º ºñÈĸ¦ °¡Á®¿Â´Ù. ¾î´À ³ªÀÌ¿¡³ª ¿Ã ¼ö ÀÖÀ¸³ª µÎ »ì ÀÌÇÏÀÇ ¾î¸°ÀÌ¿¡¼­ ¸¹ÀÌ ¹ß»ýÇÑ´Ù. ´ëºÎºÐ »ê¹ßÀûÀ¸·Î ¹ß»ýÇÏ¸ç ¼±ÃµÀû ½ÉÀå ±âÇüÀÌ ¾à 1/3¿¡¼­ ³ªÅ¸³­´Ù. ¿øÀÎÀ¸·Î »ý°¢µÇ´Â °ÍÀº Àú»ê¼ÒÁõ, ¸¸¼ºÀûÀÎ ¾Ð·Â°ú´Ù, ¿ø¹ß¼º ½É±Ù ´ë»çÀå¾Ö, ÀÚ°¡¸é¿ª¼º Áúȯ, ¼±ÃµÀûÀÎ ±âÇü, ¸²ÇÁ°ü Æó¼â, žÆÀÇ ½É³»¸·¿° µîÀÌ´Ù. ÁÂ½É½Ç ºñÈÄ ¶Ç´Â È®Àå ¶§¹®¿¡ ½ÉÀå °Å´ëÁõÀÌ ¿À¸ç ¶§·Î ´ëµ¿¸ÆÆÇ ¶Ç´Â ½Â¸ðÆÇ ÇùÂøÁõÀÌ °üÂûµÈ´Ù.
  • hyaline fibrosis
    À¯¸®Áú ¼¶À¯Áõ
  • ostitis fibrosis cystica
    ³¶Á¾ ¼¶À¯¼º °ñ¿°
  • radiation fibrosis of lung
    ¹æ»ç¼± Æó ¼¶À¯Áõ
  • retroperitoneal fibrosis
    º¹¸·ÈÄ ¼¶À¯Áõ
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
cystic fibrosis transmembrane conductance regulator Gene believed to be defective in cystic fibrosis. Gene encodes a chloride channel, homologous to a family of proteins that actively transport small solutes in an ATP dependent manner (ABC transporters).
The regulator protein is a protein which is embedded in the cell membrane and acts as a channel for certain ions to be transported into or out of the cell. The disease cystic fibrosis is caused by a defect in the gene for this protein.
(09 Oct 1997)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
cystic fibrosis <chest medicine> A generalised disorder of infants, children and young adults, in which there is widespread dysfunction of the exocrine glands, characterised by signs of chronic pulmonary disease (due to excess mucus production in the respiratory tract), pancreatic deficiency, abnormally high levels of electrolytes in the sweat and occasionally by biliary cirrhosis. There is an ineffective immunologic defense against bacteria in the lungs.
Pathologically, the pancreas shows obstruction of the pancreatic ducts by amorphous eosinophilic concretions, with consequent deficiency of pancreatic enzymes, resulting in steatorrhoea and azotorrhoea and intestinal malabsorption. The degree of involvement of organs and glandular systems may vary greatly, with consequent variations in the clinical picture.
Inheritance: autosomal recessive.
(13 Nov 1997)
cystic fibrosis antigen Now known to be MRP 8.
See: calgranulins.
(18 Nov 1997)
conductance 1. A measure of conductivity; the ratio of the current flowing through a conductor to the difference in potential between the ends of the conductor; the conductance of a circuit is the reciprocal of its resistance.
2. The ease with which a fluid or gas enters and flows through a conduit, air passage, or respiratory tract; the flow per unit pressure difference.
(05 Mar 2000)
calcium dependent regulator protein <protein> (CDRP) Early name for calmodulin.
(18 Nov 1997)
genes, regulator Genes which regulate or circumscribe the activity of other genes; specifically, genes which code for proteins (repressors or activators) which regulate the genetic transcription of the structural genes and/or regulatory genes.
(12 Dec 1998)
regulator A substance or process that regulates another substance or process.
Growth regulators, substances that can alter the growth of a living organism.
(05 Mar 2000)
regulator gene A gene that produces a repressor substance that inhibits an operator gene when combined with it. It thus prevents production of a specific enzyme. When the enzyme is again in demand, a specific regulatory metabolite inhibits the repressor substance.
(05 Mar 2000)
hepatoma transmembrane kinase <enzyme> A transmembrane tyrosine kinase of the eph subfamily; genbank u07695
Registry number: EC 2.7.1.-
Synonym: htk protein, htk gene product
(26 Jun 1999)
transmembrane Through or across a membrane.
(05 Mar 2000)
transmembrane potential <physiology> More correctly, transmembrane potential difference: the electrical potential difference across a plasma membrane.
See: resting potential, action potential.
(18 Nov 1997)
transmembrane protein <cell biology> A protein subunit in which the polypeptide chain is exposed on both sides of the membrane. The term does not apply when different subunits of protein complex are exposed at opposite surfaces. most integral membrane proteins are also transmembrane proteins.
(13 Nov 1997)
transmembrane transducer A system that transmits a chemical or electrical signal across a membrane. Usually involves a transmembrane receptor protein that is thought to undergo a conformation change that is expressed on the inner surface of the membrane. Many such transducing species are dimeric and the conformation change may involve interaction between the two components.
(18 Nov 1997)
African endomyocardial fibrosis Fibrosis of the inner layers of the myocardium, often including the endocardium, causing diastolic restriction of the heart; indigenous to East Africa.
(05 Mar 2000)
radiation fibrosis The formation of scar tissue as a result of radiation therapy to the lung.
(12 Dec 1998)
mediastinal fibrosis <radiology> Histoplasmosis most common cause, can cause superior vena cava obstruction
(12 Dec 1998)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 1 ÆäÀÌÁö: 1
  • Cystic Fibrosis Transmembrane Conductance Regulator - »õâ A chloride channel that regulates secretion in many exocrine tissues. Abnormalities in the CFTR gene have been shown to cause cystic fibrosis. (Hum Genet 1994;93(4):364-8)
    Synonyms : Protein, CFTR
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cystic fibrosis
    ³¶Æ÷¼º ¼¶À¯Áõ
  • cystic
    Æ÷³¶ÀÌ ÀÖ´Â;¹æ±¤ÀÇ;´ã³¶ÀÇ
  • fibrosis
    ¼¶À¯Áõ;¼¶À¯Çü¼º
  • regulator
    ±ÔÁ¤ÀÚ
  • regulator
    ±ÔÁ¤ÀÚ;´Ü¼ÓÀÚ;Á¤¸®ÀÚ;¼±°Å Á¶»ç(°¨½Ã)À§¿ø;Á¶Àý(Á¶Á¤)±â;(½Ã°èÀÇ)Á¤½Ã±â;Ç¥Áؽðè;¿øÄ¢;Ç¥ÁØ
  • regulator(regulatory) gene
    Á¶Àý(Á¦¾î)À¯ÀüÀÚ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á